Stock Analysis on Net
Stock Analysis on Net

Moderna Inc. (NASDAQ:MRNA)

This company has been moved to the archive! The financial data has not been updated since November 7, 2024.

Common-Size Balance Sheet: Assets 

Moderna Inc., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash and cash equivalents 15.78 12.39 27.76 35.76 14.84
Investments 30.92 25.90 15.72 27.04 54.56
Accounts receivable, net 4.84 5.36 12.87 18.95 0.34
Inventory 1.10 3.67 5.84 0.63 0.00
Prepaid services 0.99 0.84 0.51 0.21 0.53
Down payments to manufacturing vendors 0.54 0.89 0.48 2.95 0.00
Down payments for materials and supplies 0.37 0.85 1.16 0.00 0.00
Collaboration receivable 0.33 0.04 0.00 0.00 0.00
Interest receivable 0.32 0.24 0.11 0.00 0.00
Value added tax receivable 0.27 0.54 0.28 0.00 0.00
Income tax receivable 0.10 0.04 0.00 0.00 0.00
Tenant improvement allowance receivable 0.00 0.16 0.21 0.14 0.26
Prepaid income taxes 0.00 0.72 0.09 0.00 0.00
Convertible note receivable 0.00 0.14 0.00 0.00 0.00
Other current assets 0.48 0.17 0.11 0.15 0.49
Prepaid expenses and other current assets 3.40% 4.62% 2.95% 3.45% 1.29%
Current assets 56.03% 51.94% 65.15% 85.84% 71.02%
Investments, non-current 25.38 32.17 27.74 8.71 10.07
Property, plant and equipment, net 10.56 7.80 5.03 4.05 12.68
Right-of-use assets, operating leases 3.87 0.47 0.58 1.23 5.44
Deferred tax assets 0.44 3.80 1.32 0.00 0.00
Down payments and prepayments, non-current 1.86 0.00 0.00 0.00 0.00
Inventory, non-current 0.92 3.52 0.00 0.00 0.00
Equity investments 0.36 0.16 0.00 0.00 0.00
Goodwill 0.28 0.00 0.00 0.00 0.00
Finite-lived intangible asset 0.24 0.00 0.00 0.00 0.00
Restricted cash 0.02 0.05 0.00 0.00 0.00
Other 0.04 0.09 0.19 0.18 0.80
Other non-current assets 3.72% 3.82% 0.19% 0.18% 0.80%
Non-current assets 43.97% 48.06% 34.85% 14.16% 28.98%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Moderna Inc. current assets as a percentage of total assets decreased from 2021 to 2022 but then slightly increased from 2022 to 2023.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Moderna Inc. property, plant and equipment, net as a percentage of total assets increased from 2021 to 2022 and from 2022 to 2023.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Moderna Inc. non-current assets as a percentage of total assets increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.